I have seen people post about current trials and quite a few members have stated they are upwards of 25-30mg
I personally have been on 15mg for quite a while but am not going up as I am at goal.
here is more info on current trials:
The standard FDA-approved maintenance doses for tirzepatide (Mounjaro and Zepbound) cap at 15 mg weekly. Clinical trials directly investigating the
25 mg dose as a higher-tier option (alongside a 20 mg dose) are actively ongoing to evaluate its efficacy and safety for slower responders. [
1,
2,
3]
Key Details on the 25 mg Tirzepatide Clinical Trial
- Clinical Trial ID: NCT06037252
- Sponsor: Eli Lilly and Company
- Target Audience: Adults living with both obesity and Type 2 diabetes.
- Study Goal: The trial is designed specifically to test the safety, tolerability, and efficacy of investigational, higher doses (20 mg and 25 mg). It aims to determine if escalating to these levels provides enhanced glycemic control and accelerated weight loss for patients who see limited results from the 15 mg maximum. [1, 2, 3, 4]